Evaluating the Impact of Mesenchymal Stem Cell Therapy on Visual Acuity and Retinal Nerve Fiber Layer Thickness in Optic Neuropathy Patients: A Comprehensive Systematic Review and Meta-Analysis Publisher Pubmed



Chaibakhsh S^{1, 2} ; Azimi F² ; Shoaehassani A^{2, 3} ; Niknam P⁴ ; Ghamari A⁵ ; Dehghan S^{2, 3} ; Nilforushan N²
Source: BMC Ophthalmology Published:2024

Abstract

Background: Stem cell therapy has emerged as a potential therapeutic avenue for optic neuropathy patients. To assess its safety and efficacy, we conducted a systematic review and meta-analysis, focusing on the latest evidence pertaining to the improvement of visual acuity (VA) through stem cell therapy. Methods: We analyzed Each database from its inception until June 2024. PubMed, Scopus, and Google Scholar were systematically searched to identify the included studies. Data were extracted regarding the year of publication, the name of the first author, sample size, VA (Log Mar), and Retinal Nerve Fiber Layer (RNFL) thickness. PRISMA protocol was used as a guide to perform this meta-analysis. STATA 16 was used for statistical analysis. Results: A total of 66 eyes were examined in seven papers. Based on the meta-analysis, the mean VA (Log MAR) of patients with optic neuropathy improved from 0.90 to 0.65 following stem cell therapy intervention (p-value = 0.001). The thickness of the RNFLs did not demonstrate a significant change (p-value was 0.174). Conclusion: According to this systematic review and meta-analysis, stem cell therapy may improve the visual acuity of patients with optic neuropathy. Aside from the traditional therapy that can be provided to patients with optic neuropathy, stem cell therapy may also be beneficial. © The Author(s) 2024.